After adjusting for covariates, the risk of liver cancer did not reach statistical significance in patients with hepatitis B who received antihistamines (aHR = 1.22, 95% CI, 0.61–2.47) ( Figure 3 ).
← all excerpts
Treatment with Antihistamines and the Risk of Liver Cancer in Patients with Viral Hepatitis: A Multi-Center Cohort Study.
1
—
—